1. Home
  2. KURA vs CVLG Comparison

KURA vs CVLG Comparison

Compare KURA & CVLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kura Oncology Inc.

KURA

Kura Oncology Inc.

SELL

Current Price

$8.08

Market Cap

912.7M

Sector

Health Care

ML Signal

SELL

Logo Covenant Logistics Group Inc.

CVLG

Covenant Logistics Group Inc.

HOLD

Current Price

$33.27

Market Cap

867.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KURA
CVLG
Founded
2014
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Trucking Freight/Courier Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
912.7M
867.7M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
KURA
CVLG
Price
$8.08
$33.27
Analyst Decision
Strong Buy
Buy
Analyst Count
16
5
Target Price
$31.85
★ $49.50
AVG Volume (30 Days)
★ 1.6M
175.8K
Earning Date
11-10-2026
10-29-2026
Dividend Yield
N/A
★ 0.84%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.49
Revenue
$67,482,000.00
★ $705,007,000.00
Revenue This Year
$42.98
$15.65
Revenue Next Year
$116.68
$6.72
P/E Ratio
★ N/A
$68.08
Revenue Growth
★ 25.24
5.12
52 Week Low
$7.36
$18.00
52 Week High
$13.90
$49.88

Technical Indicators

Market Signals
Indicator
KURA
CVLG
Relative Strength Index (RSI) 44.48 60.91
Support Level $8.65 $33.06
Resistance Level $11.32 $35.71
Average True Range (ATR) 0.54 1.35
MACD 0.08 0.53
Stochastic Oscillator 46.95 89.74

Price Performance

Historical Comparison
KURA
CVLG

About KURA Kura Oncology Inc.

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

About CVLG Covenant Logistics Group Inc.

Covenant Logistics Group Inc together with its wholly-owned subsidiaries, offers truckload transportation and freight brokerage services to customers throughout the continental United States. The company's reportable segments include Expedited, Dedicated Services, Managed Freight, and Warehousing. The expedited segment provides truckload services to customers with high service freight and delivery standards. Dedicated segment provides customers with committed truckload capacity over contracted periods with the goal of three to five years in length. The Managed Freight segment includes brokerage services and TMS. The warehousing segment provides day-to-day warehouse management services to customers who have chosen to outsource this function.

Share on Social Networks: